Literature DB >> 6323957

Cyclic AMP-dependent regulation of activities of synthetase and phosphodiesterase of 2',5'-oligoadenylate in NIH 3T3 cells.

A V Itkes, K T Turpaev, O N Kartasheva, C A Kafiani, E S Severin.   

Abstract

Treatment of NIH 3T3 cells with adenylate cyclase activator adrenaline (10(-6) M) or cAMP phosphodiesterase inhibitor theophylline (10(-3) M) was shown to lead to intracellular cAMP elevation followed by a 2.0-to 2.5-fold increase in the 2',5'-oligoadenylate synthetase activity. This process was blocked by actinomycin D. The rise in the intracellular cAMP level was also followed by a 3-4-fold decrease in the activity of 2'-phosphodiesterase. Propranolol prevented this inhibition but actinomycin D produced only a negligible effect on the process. Incubation of the cell homogenate with purified catalytic subunit of cAMP-dependent protein kinase and ATP also resulted in a decrease of 2'-phosphodiesterase activity. These results indicate that cAMP is involved in the regulation of enzymes of the 2',5'-oligoadenylate system. The possibility that certain biological functions of cAMP are implemented via 2',5'-oligoadenylate-dependent processes is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323957     DOI: 10.1007/bf00240616

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A.

Authors:  A G Hovanessian; J Wood; E Meurs; L Montagnier
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  Kinetics of the induction of three translation-regulatory enzymes by interferon.

Authors:  A Kimchi; L Shulman; A Schmidt; Y Chernajovsky; A Fradin; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

3.  Synthesis and breakdown of pppA2'p5'A2'p5'A and transient inhibiton of protein synthesis in extracts from interferon-treated and control cells.

Authors:  B R Williams; I M Kerr; C S Gilbert; C N White; L A Ball
Journal:  Eur J Biochem       Date:  1978-12

Review 4.  Role of cyclic nucleotides in growth control.

Authors:  I H Pastan; G S Johnson; W B Anderson
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

5.  A cyclic adenosine 3',5'-monophosphate-dependent histone kinase from pig brain. Purification and some properties of the enzyme.

Authors:  M V Nesterova; L P Sashchenko; V Y Vasiliev; E S Severin
Journal:  Biochim Biophys Acta       Date:  1975-02-19

6.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

Authors:  I M Kerr; R E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

7.  Differential effects of two interferon-induced translational inhibitors on initiation of protein synthesis.

Authors:  Y Chernajovsky; A Kimchi; A Schmidt; A Zilberstein; M Revel
Journal:  Eur J Biochem       Date:  1979-05-02

8.  Interferon-induced enzymatic activities and their role in the antriviral state.

Authors:  C Baglioni
Journal:  Cell       Date:  1979-06       Impact factor: 41.582

9.  Regulation of lymphocyte mitogenesis by (2'--5') oligo-isoadenylate.

Authors:  A Kimchi; H Shure; M Revel
Journal:  Nature       Date:  1979 Dec 20-27       Impact factor: 49.962

10.  The relationship between adenosine 3':5'-cyclic monophosphate (cAMP) and interferon activity in mouse cells.

Authors:  S J Goldberg; M V O'Shaughnessy; R B Stewart
Journal:  J Gen Virol       Date:  1980-06       Impact factor: 3.891

View more
  2 in total

1.  Cyclic AMP mediates the direct antiproliferative action of mismatched double-stranded RNA.

Authors:  H R Hubbell; J E Boyer; P Roane; R M Burch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

Review 2.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.